Many hospitals finalise utilisation reviews after patients leave the facility. Payers deny claims when admission status and documentation do not match the reviewer's findings, which creates ...

Dr. Peter Churgin, a physician and early pioneer in electronic medical records, examines the growing A.I. arms race between healthcare payers and providers, and why it threatens to deepen burnout, ...

Sight Sciences stock surged on Medicare coverage for TearCare—opening a big dry eye market. Learn more about the company.

For cell therapy manufacturers such as Kite Pharma where every product is made for a single patient, labeling becomes a ...

Medical leaders reflect on 2025’s breakthroughs in AI, early detection, preventive care, and wellness—and explain how these shifts will shape healthcare priorities in 2026.

Issued on behalf of GT Biopharma, Inc.VANCOUVER, BC, Dec. 19, 2025 /PRNewswire/ -- USA News Group News Commentary – The recent FDA approval in November of the first bispecific antibody combination for ...

Q3 2025 Earnings Call Transcript December 12, 2025 Operator: BillionToOne Third Quarter 2025 Earnings Call. [Operator Instructions]. Please be advised that today’s call is being recorded. I would now ...

Cancer researchers have chased the idea of a universal cancer vaccine for decades. The promise sounds bold and almost ...

Australia's leading Neocloud (SHAZ:OTC Markets, SHAZW:OTC Markets), today announced that it has entered into a binding term sheet (the "Term Sheet") to sell its 50% interest in Texas ...

If you really want to understand 2025, do not start in Silicon Valley. Start on a construction site somewhere off a regional highway in Texas or Michigan. It is 6am. A line of cranes is lifting steel ...

Background Predicting progression to aortic valve replacement (AVR) in moderate aortic stenosis (AS) is challenging. This ...

People exploring newer weight-focused therapies often ask about the Zepbound price. Cost matters because treatment plans are ...